TAGRA 2024

Chronic wounds are a serious issues in modern healthcare, frequently resulting in prolonged patient suffering and increased healthcare expenses. Recent advances in 3D bioprinting technology have created new opportunities for development of novel therapeutic techniques. This talk addresses the potential of polymer-based drug-loaded nanoparticles developed via 3D bioprinting for chronic wound healing applications. We hope to construct scaffolds that provide structural support as well as controlled delivery of therapeutic drugs by combining biocompatible polymers and nanomaterials. The distinct features of polymer-based nanoparticles improve treatment loading capacity and release patterns, facilitating localized treatment while reducing systemic side effects. This study emphasizes 3D bioprinting's transformational significance in regenerative medicine, as well as its potential for resolving the challenges of chronic wound management. Future research will concentrate on improving the formulation and determining the in vivo efficacy of these drug-loaded nanomaterials in clinical settings.